Regulatory Briefs: IVD Draft Guidance; Dispute Panel; Risk Communication
This article was originally published in The Gray Sheet
Executive Summary
FDA releases draft guidance on human leukocyte antigen test kits. Wright Medical announces its Augment bone graft will go to FDA’s Dispute Resolution Panel. More news.
You may also be interested in...
FDA To Accept Wright’s PMA Amendment For Augment Bone Graft
The agency has agreed to accept Wright Medical’s PMA amendment for its embattled Augment bone graft, saving the firm from going to a dispute resolution panel this spring.
FzioMed Gets Second Chance For Oxiplex Gel PMA With Dispute Resolution Panel
FDA granted FzioMed’s petition for an independent review of its Oxiplex gel PMA by the Medical Devices Dispute Resolution Panel in response to FzioMed’s November 2012 petition. The agency deemed the device, intended for use in spine surgery, as “not approvable” in 2008.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.